180 related articles for article (PubMed ID: 6128357)
1. Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness.
Grewe SR; Chan SC; Hanifin JM
J Allergy Clin Immunol; 1982 Dec; 70(6):452-7. PubMed ID: 6128357
[TBL] [Abstract][Full Text] [Related]
2. Heterologous desensitization of leukocytes: a possible mechanism of beta adrenergic blockade in atopic dermatitis.
Safko MJ; Chan SC; Cooper KD; Hanifin JM
J Allergy Clin Immunol; 1981 Sep; 68(3):218-25. PubMed ID: 6114971
[TBL] [Abstract][Full Text] [Related]
3. Increased leukocyte histamine release with elevated cyclic AMP-phosphodiesterase activity in atopic dermatitis.
Butler JM; Chan SC; Stevens S; Hanifin JM
J Allergy Clin Immunol; 1983 May; 71(5):490-7. PubMed ID: 6188771
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte and monocyte localization of altered adrenergic receptors, cAMP responses, and cAMP phosphodiesterase in atopic dermatitis. A possible mechanism for abnormal radiosensitive helper T cells in atopic dermatitis.
Cooper KD; Chan SC; Hanifin JM
Acta Derm Venereol Suppl (Stockh); 1985; 114():41-7. PubMed ID: 2988252
[No Abstract] [Full Text] [Related]
5. Peripheral blood mononuclear leukocyte cyclic adenosine monophosphate specific phosphodiesterase activity in childhood atopic dermatitis.
Coulson IH; Duncan SN; Holden CA
Br J Dermatol; 1989 May; 120(5):607-12. PubMed ID: 2547417
[TBL] [Abstract][Full Text] [Related]
6. [Changed phosphodiesterase activity of leukocytes in atopic eczema].
Hanifin JM
Hautarzt; 1987 May; 38(5):258-61. PubMed ID: 3038785
[TBL] [Abstract][Full Text] [Related]
7. Functional desensitization due to stimulation of cyclic AMP-phosphodiesterase in human mononuclear leukocytes.
Chan SC; Grewe SR; Stevens SR; Hanifin JM
J Cyclic Nucleotide Res; 1982; 8(4):211-24. PubMed ID: 6300207
[TBL] [Abstract][Full Text] [Related]
8. Monocyte localization of elevated cAMP phosphodiesterase activity in atopic dermatitis.
Holden CA; Chan SC; Hanifin JM
J Invest Dermatol; 1986 Sep; 87(3):372-6. PubMed ID: 3016107
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte adherence in atopic dermatitis: diminished responses to histamine and isoproterenol.
Thulin H; Hanifin JM; Bryant R
Acta Derm Venereol; 1980; 60(3):235-8. PubMed ID: 6158226
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP-phosphodiesterase activity and histamine release in cord blood leukocyte preparations.
McMillan JC; Heskel NS; Hanifin JM
Acta Derm Venereol Suppl (Stockh); 1985; 114():24-32. PubMed ID: 2408431
[TBL] [Abstract][Full Text] [Related]
11. Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils.
Lad PM; Goldberg BJ; Smiley PA; Olson CV
Biochim Biophys Acta; 1985 Aug; 846(2):286-95. PubMed ID: 2411298
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical characterization of the distinct monocyte cyclic AMP-phosphodiesterase from patients with atopic dermatitis.
Chan SC; Reifsnyder D; Beavo JA; Hanifin JM
J Allergy Clin Immunol; 1993 Jun; 91(6):1179-88. PubMed ID: 8389777
[TBL] [Abstract][Full Text] [Related]
13. Relationship between increased cyclic AMP-phosphodiesterase activity and abnormal adenylyl cyclase regulation in leukocytes from patients with atopic dermatitis.
Hanifin JM; Lloyd R; Okubo K; Guerin LL; Fancher L; Chan SC
J Invest Dermatol; 1992 Jun; 98(6 Suppl):100S-105S. PubMed ID: 1316924
[TBL] [Abstract][Full Text] [Related]
14. Modulation of leukocyte cyclic AMP phosphodiesterase activity by recombinant interferon-gamma: evidence for a differential effect on atopic monocytes.
Li SH; Chan SC; Kramer SM; Hanifin JM
J Interferon Res; 1993 Jun; 13(3):197-202. PubMed ID: 8396165
[TBL] [Abstract][Full Text] [Related]
15. Impaired lymphocyte cyclic adenosine monophosphate responses in atopic eczema.
Archer CB; Morley J; MacDonald DM
Br J Dermatol; 1983 Nov; 109(5):559-64. PubMed ID: 6315045
[TBL] [Abstract][Full Text] [Related]
16. Elevated umbilical cord blood leukocyte cyclic adenosine monophosphate-phosphodiesterase activity in children with atopic parents.
Heskel NS; Chan SC; Thiel ML; Stevens SR; Casperson LS; Hanifin JM
J Am Acad Dermatol; 1984 Sep; 11(3):422-6. PubMed ID: 6090514
[TBL] [Abstract][Full Text] [Related]
17. Immunopharmacology of the atopic diseases.
Hanifin JM; Butler JM; Chan SC
J Invest Dermatol; 1985 Jul; 85(1 Suppl):161s-164s. PubMed ID: 2409183
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes.
Chan SC; Hanifin JM
J Lab Clin Med; 1993 Jan; 121(1):44-51. PubMed ID: 8381148
[TBL] [Abstract][Full Text] [Related]
19. Impaired monocyte cyclic AMP responses and monocyte cytotoxicity in atopic dermatitis.
Herlin T; Kragballe K
Allergy; 1980 Dec; 35(8):647-55. PubMed ID: 6261605
[TBL] [Abstract][Full Text] [Related]
20. Cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leucocytes from patients with atopic dermatitis: correlation with respiratory atopy.
Sawai T; Ikai K; Uehara M
Br J Dermatol; 1998 May; 138(5):846-8. PubMed ID: 9666832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
